Alex Miras graduated from medical school at Imperial College London, UK, and trained as a junior doctor and Specialist Registrar in Diabetes and Endocrinology in the London deanery rotations between 2002-2010. In 2010, he was awarded with a Medical Research Council (MRC) Clinical Research Training PhD fellowship, which enabled him to investigate the effects of bariatric surgery on food reward using functional neuroimaging and behavioural methodologies both in humans and rodents. He is currently a NIHR Clinical Lecturer in Metabolic Medicine at Imperial College London and interested in the mechanisms through which lifestyle interventions, pharmacotherapy, bariatric surgery and medical devices improve weight, metabolic control and diabetes-related microvascular complications.
et al., Study Protocol: A randomized controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier®) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus., Bmj Open, ISSN:2044-6055
et al., 2017, Measurement of hepatic insulin sensitivity early after the bypass of the proximal small bowel in humans, Obesity Science & Practice, Vol:3, ISSN:2055-2238, Pages:95-98
Miras AD, le Roux CW, 2017, Metabolic Surgery in a Pill, Cell Metabolism, Vol:25, ISSN:1550-4131, Pages:985-987
Panteliou E, Miras AD, 2017, What is the role of bariatric surgery in the management of obesity ?, Climacteric, Vol:20, ISSN:1369-7137, Pages:97-102
et al., 2017, Bariatric surgery makes obese patients healthier; analysis of the national bariatric surgery registry, 8th Annual Scientific Meeting of the British-Obesity-and-Metabolic-Surgery-Society (BOMSS), WILEY-BLACKWELL, Pages:15-15, ISSN:0007-1323